Parving, H. Et Al. 2012. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.367, no.23 , 2204-2213.

Parving, H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., ... Chaturvedi, N.(2012). Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.367, no.23, 2204-2213.

Parving, Hans-Henrik Et Al. "Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes," NEW ENGLAND JOURNAL OF MEDICINE , vol.367, no.23, 2204-2213, 2012

Parving, Hans-Henrik Et Al. "Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.367, no.23, pp.2204-2213, 2012

Parving, H. Et Al. (2012) . "Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.367, no.23, pp.2204-2213.

@article{article, author={Hans-Henrik Parving Et Al. }, title={Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2012, pages={2204-2213} }